China Tracker - Safety/Risk Model (Stage One) for American Oriental Bioengineering (AOBI)

 American Oriental Bioengineering
 Going Public
Market Segment:
Going Public: 2001-12-18Reverse Merger
RTO Advisor: Mid-Continental Securities 
 Auditor
Auditor: Weinberg & Company
Number of Auditors (since Jan 1, 2009): 4
Auditor Resignations (since Jan 1, 2009): none 
 Internal Controls
Internal Controls (Management): effective
Internal Controls (Audit): effective
Senior Management Changes (since Jan 1, 2009): 0 
Number of CFOs (since Jan 1, 2009): 1 
CFO Resignations (since Jan 1, 2009): none 
Main Shareholder (Tony Liu): Chairman, CEO 
Ownership Percentage: 18.60% 
 Analyst Coverage
Total Coverage: 4 Analyst(s) 
Tier 1 Firms: 0 Analyst(s) 
Tier 2/3 Firms: 4 Analyst(s) 
 Indicators
New Shares / Dilution (TTM): -11.28 million-12.61%
Short Interest: no data 
Account Receivables (MRQ): $46.87 million11.99% 
 Recent Events
Delinquent with SEC Filings: YES
Short Seller Attacks (Corporate Governance): NO 
Detailed Fraud Allegations: NO 
 
 Auditor History (since January 1, 2009)
2012-06-15Weinberg & CompanyAppointment
2012-06-15Ernst & YoungDismissal
2009-08-10Ernst & Young Hua MingAppointment
2009-08-10Weinberg & CompanyDismissal
 Senior Management Trail (since January 1, 2009)
2007-05-01Yanchun LiCFOAppointment
AOBI
Healthcare & Drugs
SAFETY/RISK SCORE
40%
HIGH RISK
Detailed Score: 322.5/800
Current Price:  $5.00
F10k Day (2002-02-22): 566.66%$0.75
2009 Close: 7.52%$4.65
2010 Close: 108.33%$2.40
High (2012-03-14): 214.46%$1.59
Low (2012-07-13): 9,900.00%$0.05
Exchange: PNK
Market Capitalization: 390.89 mill
Total Shares: 78.18 mill
Float: n/a
Last Quarter: 2011-03-31
Revenue (MRQ): 52.00 mill
Net Income (MRQ): 0.92 mill
Op. Cash Flow (MRQ): 21.60 mill
all financial data provided without warranty